Astley-Sparke Philip 4

What Happened

• Philip Astley‑Sparke, a director of Replimune Group, sold 17,657 shares of REPL on May 18, 2026. The filing reports aggregate proceeds of $89,698. The reported per‑share price is shown as $5.08; the filer notes a weighted average sale price ranged from $5.02 to $5.08.

Key Details

• Transaction date: 2026-05-18; Form 4 filed 2026-05-20 (appears timely).
• Reported shares sold: 17,657; reported proceeds: $89,698.
• Price details: weighted average price between $5.02 and $5.08; filing lists $5.08.
• Footnote: Sale was a "sell to cover" to satisfy tax withholding for partial vesting of RSUs and was not a discretionary sale by the reporting person (F1).
• Filing does not disclose shares owned by the reporting person after the transaction in the provided excerpt.

Context

• This was a tax‑withholding sale tied to RSU vesting (a routine administrative transaction), not an open-market discretionary sell motivated by investment views. Such "sell to cover" transactions are common when restricted stock units vest and taxes are due.